CPT Coding Developments for Molecular Pathology Procedures and Their Impacts on the Field at Large

Session Description: The Economic Affairs Committee (EAC) invites you to attend a discussion on the challenges of delivering patient care in this new economic landscape, with a focus on the Protecting Access to Medicare Act (PAMA), New Current Procedural Terminology (CPT) Codes and Prior Authorization. It is crucial that laboratories and molecular diagnostics professionals understand the coverage and reimbursement landscape of molecular diagnostics in today’s healthcare system. The session will explore the impacts and future implications of PAMA, educate members on new CPT codes that will be implemented for CY2024, and discuss challenges related to the implementation of prior authorization in the laboratory setting. The EAC addresses, advises, and educates the AMP Board of Directors, membership, payers, legislators, and the public on economic issues of importance to the field of molecular pathology and develops and advocates for sound economic policies that promote the provision of high-quality molecular pathology services.